Goldman Sachs Group Inc Neuroone Medical Technologies Corp Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 98,573 shares of NMTC stock, worth $60,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98,573
Previous 98,573
-0.0%
Holding current value
$60,129
Previous $83,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NMTC
# of Institutions
21Shares Held
1.93MCall Options Held
69.6KPut Options Held
2K-
Vanguard Group Inc Valley Forge, PA1.11MShares$677,5200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA346KShares$211,0450.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.81KShares$49,4100.0% of portfolio
-
State Street Corp Boston, MA59.5KShares$36,2940.0% of portfolio
-
Blair William & CO Chicago, IL55.6KShares$33,8890.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $9.89M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...